** Shares in Eurobio Scientific ALERS.PA rise 4.8% after
the France-based biotech company said its reference shareholders
will join forces with NextStage AM and Nextstage SCA
urn:newsml:reuters.com:*:nGNE34fbmY
** Under the agreement, Nextstage AM will invest EUR 35.5
million ($40.58 million) in EurobioNext, a new holding company
to be set up by Jean-Miche Carle Grandmougin, chairman of
Eurobio's management board, and board member Denis Fortier
** Grandmougin and Fortier will own around 56.5% of the new
company, while NextStage SCA and the FPCI Pépites et Territoires
will hold 43.5%
** The stock, down 16% YTD, is on track for its best day
since Dec. 30, 2021
($1 = 0.8747 euros)
(Reporting by Olivier Sorgho in Gdansk)
((olivier.sorgho@thomsonreuters.com))